Business News • PR NewsWire • Immune Pharmaceuticals Announces Second Quarter 2014 Financial Results and Provides Update on Bertilimumab Commencement of Phase II Clinical Trials

Immune Pharmaceuticals Announces Second Quarter 2014 Financial Results and Provides Update on Bertilimumab Commencement of Phase II Clinical Trials

Immune Pharmaceuticals Announces Second Quarter 2014 Financial Results and Provides Update on Bertilimumab Commencement of Phase II Clinical Trials

CAMBRIDGE, Mass. and HERZLIYA-PITUACH, Israel, Aug. 14, 2014 /PRNewswire/ -- Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX First North Premier, Stockholm: "IMNP"), announced today its operating results for the quarter ended June 30, 2014. Dr. Daniel Teper, Chief Executive...

View More : http://www.prnewswire.com/news-releases/immune-pharmaceuticals-announces-second-quarter-2014-financial-results-and-provi...

Releted News by prnewswire

CareerBuilder and Economic Modeling Specialists List the Best Paying Jobs for Workers with High School Degrees

Principaux tendances et modèles d'investissement en matière de technologie financière pour la période 2014-2016

Near Field Communication (NFC) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

August's National Startup Pitch Competition Features Social Entrepreneurs